A binding site model and structure-activity relationships for the rat A3 adenosine receptor

PJ van Galen, AH van Bergen, C Gallo-Rodriguez, N Melman, ME Olah, AP IJzerman, GL Stiles and KA Jacobson

Molecular Recognition Section, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

A novel adenosine receptor, the A3 receptor, has recently been cloned. We have systematically investigated the hitherto largely unexplored structure-activity relationships (SARs) for binding at A3 receptors, using 125I-N6-2-(4-aminophenyl)ethyladenosine as a radioligand and membranes from Chinese hamster ovary cells stably transfected with the rat A3-cDNA. As is the case for A1 and A2a receptors, substitutions at the N6 and 5' positions of adenosine, the prototypic agonist ligand, may yield fairly potent compounds. However, the highest affinity and A3 selectivity is found for N6,5'-disubstituted compounds, in contrast to A1 and A2a receptors. Thus, N6-benzyladenosine-5'-N-ethylcarboxamide is highly potent (Ki, 6.8 nM) and moderately selective (13- and 14-fold versus A1 and A2a). The N6 region of the A3 receptor also appears to tolerate hydrophilic substitutions, in sharp contrast to the other subtypes. Potencies of N6,5'-disubstituted compounds in inhibition of adenylate cyclase via A3 receptors parallel their high affinity in the binding assay. None of the typical xanthine or nonxanthine (A1/A2) antagonists tested show any appreciable affinity for rat A3 receptors. 1,3-Dialkylxanthines did not antagonize the A3 agonist-induced inhibition of adenylate cyclase. A His residue in helix 6 that is absent in A3 receptors but present in A1/A2 receptors may be causal in this respect. In a molecular model for the rat A3 receptor, this mutation, together with an increased bulkiness of residues surrounding the ligand, make antagonist binding unfavorable when compared with a previously developed A1 receptor model. Second, this A3 receptor model predicted similarities with A1 and A2 receptors in the binding requirements for the ribose moiety and that xanthine-7-ribosides would bind to rat A3 receptors. This hypothesis was supported experimentally by the moderate affinity (Ki 6 microM) of 7-riboside of 1,3- dibutylxanthine, which appears to be a partial agonist at rat A3 receptors. The model presented here, which is consistent with the detailed SAR found in this study, may serve to suggest future chemical modification, site-directed mutagenesis, and SAR studies to further define essential characteristics of the ligand-receptor interaction and to develop even more potent and selective A3 receptor ligands.

Volume 45, Issue 6, pp. 1101-1111, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman Purinergic receptors in gastrointestinal inflammation Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410. [Abstract] [Full Text] [PDF]

				M. F. Ethier and J. M. Madison Adenosine A1 Receptors Mediate Mobilization of Calcium in Human Bronchial Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 496 - 502. [Abstract] [Full Text] [PDF]

				M. Kukley, P. Stausberg, G. Adelmann, I. P. Chessell, and D. Dietrich Ecto-Nucleotidases and Nucleoside Transporters Mediate Activation of Adenosine Receptors on Hippocampal Mossy Fibers by P2X7 Receptor Agonist 2'-3'-O-(4-Benzoylbenzoyl)-ATP J. Neurosci., August 11, 2004; 24(32): 7128 - 7139. [Abstract] [Full Text] [PDF]

				L. Yip and Y. N. Kwok Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 804 - 815. [Abstract] [Full Text] [PDF]

				S. M. Gopalakrishnan, S. A. Buckner, I. Milicic, D. R. Groebe, K. L. Whiteaker, D. J. Burns, U. Warrior, and M. Gopalakrishnan Functional Characterization of Adenosine Receptors and Coupling to ATP-Sensitive K+ Channels in Guinea Pig Urinary Bladder Smooth Muscle J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 910 - 917. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF]

				S. A. Rivkees, H. Barbhaiya, and A. P. IJzerman Identification of the Adenine Binding Site of the Human A1 Adenosine Receptor J. Biol. Chem., February 5, 1999; 274(6): 3617 - 3621. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF]

				J. Zhang, L. Belardinelli, K. A. Jacobson, D. H. Otero, and S. P. Baker Persistent Activation by and Receptor Reserve for an Irreversible A1-Adenosine Receptor Agonist in DDT1 MF-2 Cells and in Guinea Pig Heart Mol. Pharmacol., September 1, 1997; 52(3): 491 - 498. [Abstract] [Full Text]

				J. A. Auchampach, A. Rizvi, Y. Qiu, X.-L. Tang, C. Maldonado, S. Teschner, and R. Bolli Selective Activation of A3 Adenosine Receptors With N6-(3-Iodobenzyl)Adenosine-5'-N-Methyluronamide Protects Against Myocardial Stunning and Infarction Without Hemodynamic Changes in Conscious Rabbits Circ. Res., June 19, 1997; 80(6): 800 - 809. [Abstract] [Full Text]

				T. V. Dunwiddie, L. Diao, H. O. Kim, J.-L. Jiang, and K. A. Jacobson Activation of Hippocampal Adenosine A3 Receptors Produces a Desensitization of A1 Receptor-Mediated Responses in Rat Hippocampus J. Neurosci., January 15, 1997; 17(2): 607 - 614. [Abstract] [Full Text] [PDF]

				J. Kim, Jür. Wess, A. M. v. Rhee, T. Schöneberg, and K. A. Jacobson Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A[IMAGE] Adenosine Receptor J. Biol. Chem., June 9, 1995; 270(23): 13987 - 13997. [Abstract] [Full Text] [PDF]